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Abstract 
Background: This study examined whether temporal trends exist in treatment of patients 
with type 2 diabetes (T2D) and quality of diabetes care after implementation of quality 
improvement initiative in primary care setting. 
Methods: We conducted a population-based retrospective cohort study of 202,284 patients 
with T2D who were routinely managed in primary care clinics. We examined the change over 
time and the variability between clinics in quality-of-care from Hospital Authority 
administrative data over a five-year period (2009-2013), and used multilevel logistic 
regression to adjust for patient and clinic characteristics. Observational period was partitioned 
in five calendar years. Ten quality-of-care criteria were selected: adherence to seven process 
of care criteria (HbA1c test, renal function test, full lipid profile, urine protein analysis, 
retinal screening, lipid-lowering agent prescriptions among patients with 
hypercholesterolaemia, and ACEI/ARB prescriptions among patients with microalbuminuria) 
and three outcome of care criteria (HbA1c≤7%, BP≤130/80mmHg, LDL-C≤2.6mmol/L). 
Variability of standards between clinics was assessed using intra-cluster correlation 
coefficients. 
Results: Characteristics of Patients with T2D managed in primary care changed substantially 
during the observational period, with increasing age and usage of insulin, longer duration of 
diabetes but improved metabolic profiles (all P-trend<0.001). Performance rates of the seven 
process and three clinical outcome of care criteria increased remarkably over time (all P-
trend<0.001). Variations in retinal screening delivery between clinics was considerable, albeit 
decreasing over time. 
Conclusions: Coinciding with implementation of quality improvement initiative, quality of 
diabetes care improved significantly in the past 5 years, in part attributable to benefits of 
integrated multidisciplinary diabetes management. 
Trial registration: Not applicable 
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List of abbreviations 
 
T2D = Type 2 Diabetes 
DM = Diabetes mellitus 
RAMP-DM = Multidisciplinary Risk Assessment and Management Program for Patients with 
Diabetes Mellitus  
PEP = Patient Empowerment Programme 
ICPC-2 = International Classification of Primary Care, Second Edition  
LDL-C = low-density lipoprotein–cholesterol  
ACEI = angiotensin converting enzyme inhibitors (ACEI)  
ARB = angiotensin receptor blockers  
BP = blood pressure 
OR = odds ratios  
ICC = intra-class correlation 
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Manuscript 
 
Introduction 
 
Over the past decades, an integrated service model involving risk stratification[1], 
personalized treatment[2, 3] and multidisciplinary management[4, 5] have played an 
increasingly important role in the care/management of patients managed in the primary care 
setting. Such service model for patients with diabetes mellitus (DM) enhanced quality of 
care, leveraged better metabolic control as intermediate clinical outcomes, and early detection 
and prevention in diabetic complications. Furthermore, the launch of such service model 
within healthcare system can be regarded as the implementation of a quality improvement 
initiative that leads to measureable improvement in quality of care through continuous actions 
and efforts[6]. 
 
Many developed countries have implemented quality improvement initiatives to successfully 
improve the quality of diabetes care[7-14]. However, in Hong Kong, there was no prior 
development of diabetes care guidelines and implementation of quality improvement 
initiatives. In response to this evidence at policy level, the Hong Kong Hospital Authority 
reformulated their delivery and coverage of diabetes management in primary care. From 2009 
onwards, the Hospital Authority has launched a quality improvement initiative, composing a 
series of primary care interventions, aiming at improving well-being of and quality of care for 
patients with chronic diseases, diabetes in particular. Coproduction of the two interventions 
(Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes 
Mellitus; RAMP-DM) [15-19] and Patient Empowerment Programme; PEP) [20-26]) 
designated to innovate a more proactive and holistic approach in providing risk assessment 
for diabetic complications multi-faceted management, structured education and patient 
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empowerment for self-management. Enrollment to RAMP-DM, PEP or other interventions 
are offered to patients with newly diagnosed DM, where the overlapping interventions exists. 
In the period of 2009-2013, sequential implementation of RAMP-DM and PEP has 
aggregated substantial clinical benefits to participants and modest reductions in utilization of 
secondary care[24]. The PEP led to the benefits of substantial reductions in the frequency of 
emergency department visits and hospitalization episodes, and their associated direct medical 
costs[24]. Despite the considerable manpower and resources allocated to enhance the 
efficiency of diabetes management, comprehensive picture of temporal trends in process and 
clinical outcome of patients associated with the quality improvement initiative are lacking. 
 
This study examined the inter-clinic variability and temporal trends in the treatment of 
patients with type 2 diabetes (T2D) and quality of diabetes care after implementation of 
quality improvement initiative in the primary care. We hypothesized that the decrease in 
variability between clinics, improved quality of diabetes care, and changes in treatment of 
patients with T2D were observed after implementation. 
 
Method 
 
Study design and cohort 
 
A longitudinal, retrospective population-based study was conducted in 72 primary care clinics 
using the clinical management system administrative database of the Hong Kong Hospital 
Authority. All patients with T2D who had attended at least one general out-patient clinic or 
family medicine specialist clinic on any date between 1 January 2009 and 31 December 2013, 
and were identified with the International Classification of Primary Care, Second Edition 
(ICPC-2) diagnosis codes of ‘T90’ (Non-insulin dependent diabetes), were included to 
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measure the observed standard of care in the process and clinical outcomes of care criteria. 
Patients with diabetes who were managed by endocrinologists in specialist outpatient clinics 
were excluded. Out of 74 clinics, two clinics (2.7%) were not operated concurrently in all 
five years between 2009 and 2013 due to reconstruction or suspension so 72 (97.3%) clinics 
were included for analysis. General outpatient clinics in the Hospital Authority provided 
primary care services for >170,000 adults with diabetes annually, of whom 202,284 patients 
with T2D were included for analysis due to multiple visits of the same patients in each of the 
year from 2009 to 2013. Data from clinical management system administrative database were 
retrieved from Hong Kong Hospital Authority Statistics and Workforce Planning Department 
at April 2014. 
 
Intervention 
 
Quality improvement initiative for diabetes care in primary care setting composes of two 
major interventions: RAMP-DM and PEP. In brief, T2D patients participating in RAMP-DM 
were offered a comprehensive risk factor screening for diabetic complications. A nurse 
assessed the screening results and stratified patients into ‘low’, ‘medium’, ‘high’ or ‘very 
high’ risk group. Based on individual risk stratification, patients were assigned to receive 
interventions provided by a multidisciplinary team (physicians, nurses, optometrist, dietitian, 
podiatrist, physiotherapist, and other allied health professionals). Comprehensive screening 
and assessments were periodically repeated every one to two years according to patients’ 
stratified risk levels. The PEP is a structured diabetes education program aiming at providing 
knowledge and skills, increasing self-awareness with regards to their own disease condition, 
and facilitating autonomous self-regulation. The education curriculum of PEP included both 
diabetes-specific and generic sessions. Diabetes-specific sessions covered comprehensive 
information about diabetes, responsibility of self-care management, medications in diabetes 
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control, and contingency management on hypo- and hyperglycemia. Generic sessions covered 
the importance of self-management and behavior modification, healthy diet and regular 
exercise habit, goal setting, problem solving skills, stress coping management, psychosocial 
support and networking, and communications with healthcare professionals. Full details of 
RAMP-DM [15-19] and PEP[20-26] have been described elsewhere. 
 
Quality of Care Measures 
 
The evaluation of quality of diabetes care was primarily based on the classical taxonomy 
described by Donabedian et al[27, 28]. The approaches of Plan-Do-Study-Act model, Action 
Learning and Audit Spiral Methodologies were adopted in quality of care evaluation. The 
applicability and logistics of the implementation of the primary care interventions were 
discussed with key service providers in planning and feedback meetings. Feedback on the 
evaluation results with benchmark comparison were given to the Hospital Authority 
intervention teams to identify deficiencies, difficulties, recommendations to address issues 
encountered or anticipated, and further areas for quality of care enhancement. Multiple site 
visits were made regularly to understand gaps between the actual practice and intended 
intervention operation.  
 
Development of evaluation framework and quality of diabetes care criteria have been 
described previously[29]. A evidence-based evaluation framework for process or outcome of 
care criteria was identified by literature review, international guideline [8, 30-32] and local 
reference framework[33], and further established by an iterative consultation process between 
Hospital Authority primary care working group and the University of Hong Kong research 
team.  
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Quality of care was measured by ten diabetes care quality criteria in evaluation framework, 
with breakdown of seven process criteria and three outcome criteria. In this study, process of 
care criteria were receipt of HbA1c measurement within the past one year, renal function test 
within the past one year, full lipid profile within the past one year, urine protein analysis (i.e. 
available for one of the following measurements: albumin creatinine ratio, protein creatinine 
ratio, albumin concentration, albumin excretion rate, 24-hour urine albumin, 24-hour urine 
protein, or urine for protein/albumin stick) within the past one year, retinal screening with 
retinal photo examination within the past one year, lipid-lowering agent prescriptions among 
patients with hypercholesterolaemia (defined as low-density lipoprotein–cholesterol (LDL-C) 
> 2.6 mmol/L), and angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor 
blockers (ARB) prescriptions among patients with microalbuminuria (defined as urine 
albumin/creatinine ratio 2.5-<25 mg/mmol in men and 3.5-<25 mg/mmol in women in both 
the first and repeated records). Clinical outcomes of care criteria were the proportion of 
patients with HbA1c level of 7% or less, proportion of patients with blood pressure (BP) 
reading of 130/80 mmHg or less, and proportion of patients with LDL-C level of 2.6 mmol/L 
or less. 
 
Each quality of care criteria was evaluated in annual basis over five-year observation period, 
in exception with receipt of diabetic retinopathy (DMR) screening. The procedure code of 
retinal screening undertaken at primary care clinic was introduced in early 2009 when the 
first record of that procedure code was earlier than the implementation of quality 
improvement initiative. To avoid miscoding and misclassification bias, criteria of retinal 
screening was evaluated over period studied from 2010 to 2013. 
 
Statistical Analysis 
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Characteristics of patients and clinics were summarized as mean and standard deviation for 
continuous variables and proportion for categorical variables by calendar years.  
 
Crude performance rate to process and outcome of care criteria at patient level was calculated 
by years. For each quality criterion, crude performance rate was calculated by the number of 
eligible T2D patients adhered to the criteria by the end of the year divided by the total 
number of eligible T2D patients ever attending primary care outpatient clinics at the year. In 
particular, patients with hypercholesterolaemia and patients with microalbuminuria were 
eligible for quality criterion of prescription of lipid-lowering agent and prescription of 
ACEI/ARB, respectively. Trends in unadjusted process and outcome of care criteria over the 
five-year period of analysis were examined by the Cochran-Armitage χ2 test. 
 
To examine secular trends in the quality of care between 2009 and 2013, a multivariable 
multi-level logistic regression analysis was performed when correcting for clustering on the 
clinic levels, adjusting for confounding patient and clinic characteristics. Odds ratios (OR) 
and 95% confidence intervals were reported for outcomes in three dummy variables 
representing the time period of 2010-2013 with 2009 as the reference year. Reference 
category was year 2010 for DMR screening as outcome since DMR data in 2009 were not 
excluded from analysis.  
 
To analyze the variability of quality of care for clinic level, we calculated the intra-cluster 
correlation (ICC) coefficients, as a ratio of the between-clinic variance and the variance of 
between-and within-clinic variances, for each quality criteria. The ICC means the extent of 
variability in quality criteria explained by the differences between clinics. A higher ICC at the 
clinic level reflects a smaller variance for quality criteria within the clinics and a larger 
variance between clinics. 
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All statistical analyses were performed using STATA Version 13.0 (StataCorp LP. College 
Station, Texas, U.S.), specifying commands of xtmelogit procedure for multi-level mixed-
effects logistic regression[34]. All significance tests were two-tailed and those with a P-value 
less than 0.05 were considered statistically significant. 
 
Results 
 
A total of 170,000-190,000 eligible subjects with T2D among 72 clinics in Hong Kong were 
identified and included in the analysis each year. Table 1 shows their socio-demographics and 
clinical characteristics across the observational period. Larger proportions of smoker, current 
drinker and subjects with higher educational level were observed every year. Moreover, there 
was a significant trend of increasing age, decreasing lipid profile, longer duration of DM, 
higher proportion of subjects with hypertension and increasing usage of insulin. 
 
Enrollment to RAMP-DM and PEP were referred through physicians and nurses at general 
outpatient clinics. Across a five-year time frame, there was a substantial increase in the 
coverage rate of RAMP-DM (from 2.7% in 2009 to 81.9% in 2013)[35] and PEP (from 2.1% 
in 2010 to 13.4% in 2013) interventions, most of T2D patient (82.4%) enrolling one of the 
interventions under quality improvement initiative at the end.  
 
Table 2 depicts the performance rates of seven process and three clinical outcomes of care 
criteria over time. All process of care criteria except DMR screening showed trends of 
improvements. For instance, the annual HbA1c test increased from 70.84% in 2009 to 
90.67% in 2013; the renal function test increased from 56.59% in 2009 to 91.69% in 2013; 
the prescriptions of lipid-lowering agent for patients with hypercholesterolaemia and 
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ACEI/ARB for patients with microalbuminuria increased by 54.03% and 12.86%, 
respectively in five years’ time. For clinical outcomes of care criteria, there were also 
monotonic increments observed for the proportions of patients with BP ≤ 130/80mmHg (from 
31.51 % in 2009 to 48.21% in 2013) and LDL-C ≤ 2.6mmol/L (from 28.29% in 2009 to 
65.44% in 2013) across the observational period. 
 
The unadjusted multi-level mixed effects logistic regressions were performed for each of the 
process and clinical outcomes of care criteria and the results are presented in Table 3. Taking 
2009 as the reference year, subjects in the subsequent years had increasing odds of meeting 
the process and clinical outcomes of care criteria, as reflected by all the odds ratios exceeding 
1. For example, subjects in 2013 had more than nine-fold odds of having annual test for renal 
function and full lipid profile, comparing with those in 2009. However, the effect on clinical 
outcomes of care criteria was not as strong as that on process of care criteria. Subjects in 
2013 only had odds ranging from 2 to 4, though significant, of meeting the targets for 
HbA1c, BP and LDL-C, comparing with those in 2009. These results are in line with that 
presented in Table 2. Same regression models were fitted with the adjustment of patient’s 
baseline and clinic characteristics, and clinic treated as the random effect. The effects on most 
of the process and outcome of care criteria were diluted, as reflected by the decrement in the 
(adjusted) odd ratios in Table 4. However, the effects were still highly significant when 
comparing with the data in 2009. 
 
Discussions 
 
This retrospective cohort study revealed an absolute increment in the performance of diabetes 
measurements in Hong Kong primary care setting between 2009 and 2013. The principal 
findings reflected a key achievement of quality improvement initiative, supporting our priori 
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hypothesis that such initiative improved quality of diabetes care, especially process of care, 
and decreased the variability of quality of care. After implementation of quality improvement 
initiative, trends in quality of diabetes care over time were moving upward visibly from 
uncorrected crude performance rates, demonstrating that proportions of adherence to six out 
of seven process criteria exceeded 70%, and proportions of adherence to two out of three 
outcome criteria exceeded 60%. After multi-level analysis with correlation for clustering 
effects within clusters, the odds of adherence to process or outcome of care were statistically 
higher for T2D patients managed in primary care clinics in 2013 than in earlier years when 
quality of care was comparatively low at baseline. Despite remarkable improvement in 
overall quality of care in the past 5 years, our results underlined that there is room for 
improvement in three clinical outcomes and process of retinal screening. Thus, improvement 
in process of care accelerated in the first three years (2009-2011) of the quality improvement 
initiative but velocity for the improvement attenuated in the fourth and fifth year (2012-2013) 
(Figure 1). Our findings were in parallel with trends in quality of diabetes care after a 
complex intervention in many developed countries. For instance, longitudinal analyses of 
patient individual data in the UK[7-9] disclosed such similar trends for the improved quality 
of diabetes care over time, accelerating in early year period after introduction of Quality and 
Outcomes Framework[8, 9] and financial incentive scheme[7] but attenuating velocity for the 
improvement afterwards. Furthermore, analyses of serial cross-sectional surveys in the 
US[10, 11] and Norway[12] reported substantial improvements in quality of care over time. 
 
Striking improved trends identified in this five-year data could be attributable to a potential 
paradigm shift in the Hong Kong primary care interventions for diabetes, including 
implementation of quality improvement initiative, increasing physician referral to individual 
primary care interventions, or increasing patient participation in interventions. Indeed, the 
RAMP-DM intervention has provided periodic screening and assessments for diabetic 
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complication, fueling temporal growth in performance rates of process criteria. Furthermore, 
individual primary care interventions have undergone multiple feedback meetings under 
quality of care evaluation with adoption of Action Learning approach. Feedback to designed 
cluster coordinators has affected how frontline health professionals evolved major changes in 
routine practice to primary care clinics. On a hand, following feedback provided by 
coordinators, revision of quality criteria or benchmarked standard of criteria has contributed 
to quality of care improvement. 
 
Patient characteristics with respect to demographics and clinical risk profiles change rapidly 
in T2D patients routinely managed in Hong Kong public primary care setting, including an 
aging population, a greater proportion with long duration of diabetes diagnosis (5 years or 
above), a greater proportion with history of hypertension, and more initiation of insulin. 
Changes in patient characteristics in this cohort were somewhat different to those in the UK 
primary care system[7], of which the characteristics slightly varied over the years. Yet, given 
progressively worsened clinical risk profile of this cohort, improvement in quality of care 
persisted with the concerted and continued effort in quality improvement initiative.  
 
Our results added to current literature that implementation of quality improvement imitative 
reduced the disparities between clinics over time. The quality improvement initiative 
demonstrated considerably reduced variability in process of care criteria between clinics, as 
reflected by renal function test, full lipid profile test, urine protein analysis, lipid-lowering 
agent prescription and retinal screening. Similar observations that velocity for the 
improvements in healthcare quality may diminish over time were documented in the 
literature[36]. Publication of performance measure[37], audit feedback evaluation cycles[37], 
and sustainability efforts to expand the use of electronic medical records[38] are associated 
with sustained improvement in quality of diabetes care. Furthermore, inter-clinic variability 
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or heterogeneity seen in retinal screening delivered in primary care clinics decreased from 
2009 to 2013, mainly attributable to the commencement of systematic retinal screening[39] 
as part of the RAMP-DM. However, despite an increased number of onsite fundus 
photography available during a 5-year period, only 30 out of 74 clinics (40.54%) installed 
with onsite digital fundus photography. Access to advocate timely systematic screening to 
patients who needed was limited, leading to low proportion of patients receiving retinal 
screening. Such structured barriers limited the performance rates of retinal screening and ever 
screening coverage. According to English NHS diabetic eye screening programme data[40], 
longer duration between DM diagnosis and first screening of diabetic retinopathy was 
associated with increased detection of severe stages of retinopathy such as referable diabetic 
retinopathy. 
 
Existing pool of individual criteria is insufficiently evaluating the overall performance and 
quality of care of a primary care clinic. Complementary use of both composite measure and 
individual criteria had strategic implications for quality improvement plan at the clinic level. 
Clinics aiming for excellent overall performance might prioritize their efforts on individual 
criteria in low tier level of standard, whereas clinics striving for a specific care improvement 
might target only improvement in individual criteria to top tier level of standard. 
 
Limitations 
Performance rates of process criteria have only accounted for procedural coding of testing 
utilized in general outpatient clinics under primary care setting; we did not include procedural 
coding of testing occurring during the hospitalization and specialist outpatient clinics. 
Moreover, the procedural code of retinal screening was incomplete in 2009 data with a 
limited four-year assessment, in opposite to five-year assessment for other quality criteria. 
Secondly, administrative data before implementation of quality improvement initiative were 
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not available to assess quality of diabetes care at 2008 or earlier years. Our team got access to 
data over the period between 1 January 2009 and 31 December 2013. Therefore, our results 
were implausible to identify the extent of quality improvement at base year when compared 
to previous years. Thirdly, the reduction of diabetic complication due to the quality 
improvement initiative was not evaluated, although the decreases in incidence of diabetic 
complication and death are regarded as net clinical benefit of intervention. However, the 
design of this study evaluated the performance rate of quality criteria by years. Due to the 
low annual incidence of diabetic complication in primary care setting, the incidence of 
diabetic complication was not one of the outcome criteria in evaluation framework. 
Moreover, the calculation of performance rate of quality of care criteria in this study only 
involved patients who visited the clinics during the observation period, whereas patients with 
undiagnosed diabetes were not captured in database. Those patients may have better clinical 
measures and thus overestimate performance rates. In cases when clinics had under-detection 
of hypercholesterolaemia or microalbuminuria, criteria of lipid-lowering agent prescription or 
ACEI/ARB prescription might perform better. Finally, the improved performance of diabetes 
measurements may be partly attributable to implementation of other factors or government-
driven policy such as the release of Reference Framework for Diabetes Care for adults[33] in 
2010 which was found to be highly adopted among primary care physicians[41].  
 
Conclusions 
 
Performance of quality measurements of DM care at the primary care setting improved 
significantly in the past 5 years after implementation of quality improvement initiative. 
Improvement in performance of diabetes measurements was in part attributable to benefits of 
integrated service model involving personalized medicine and multidisciplinary diabetes 
management. However, due to the structural barriers to undertake retinal screening, 
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performance rates of retinal screening increased with the growing ratio of onsite fundus 
photography in primary care clinics during the evaluation period but such screening coverage 
remained for further improvement.  
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Figure Legends 
 
Figure 1. Yearly temporal trends of process of care criteria performance rate and coverage 
rate of quality improvement initiative 
Figure 2. Yearly temporal trends of outcome of care criteria performance rate and coverage 
rate of quality improvement initiative 
 
Appendix 
Appendix 1. Intra-cluster correlations of process of care criteria from 2009 to 2013 
Appendix 2. Intra-cluster correlations of outcome of care criteria from 2009 to 2013 
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Table 1. Characteristics of Diabetic Patients Managed and Routinely Visited in Primary Care Outpatient Clinics Over Time
Variable 2009 2010 2011 2012 2013 P-value for trend
Number of diabetic patients 172,551 178,993 184,690 180,108 172,543
Socio-Demographic
Age (mean±SD, n), year 66.09±12.08 (172,551) 66.46±12.03 (178,993) 66.86±12.01 (184,690) 67.62±11.87 (180,108) 68.38±11.71 (172,543) < 0.001*
Gender (%, n) 1.000
Female 55.42 % (95,634) 54.95 % (98,360) 54.41 % (100,484) 54.41 % (97,988) 54.60 % (94,211)
Male 44.58 % (76,917) 45.05 % (80,633) 45.59 % (84,206) 45.59 % (82,120) 45.40 % (78,332)
Smoking status (%, n) < 0.001*
Non-smoker 94.74 % (71,814) 93.19 % (87,455) 93.09 % (101,494) 91.51 % (88,929) 91.46 % (73,097)
Smoker 5.26 % (3,991) 6.81 % (6,389) 6.91 % (7,535) 8.49 % (8,252) 8.54 % (6,823)
Alcohol status (%, n) < 0.001*
Non-drinker 84.38 % (39,210) 83.02 % (59,273) 82.46 % (68,818) 82.63 % (65,207) 82.05 % (53,060)
Drinker 15.62 % (7,258) 16.98 % (12,122) 17.54 % (14,636) 17.37 % (13,712) 17.95 % (11,605)
Educational level (%, n) < 0.001*
No formal education/ Primary 60.12 % (28,955) 58.28 % (43,677) 58.05 % (51,393) 57.01 % (52,759) 57.25 % (44,703)
Secondary/ Tertiary 39.88 % (19,211) 41.72 % (31,272) 41.95 % (37,132) 42.99 % (39,791) 42.75 % (33,381)
Laboratory Results at Baseline (mean±SD, n)
BMI, kg/m2 25.62±3.92 (73,382) 25.48±3.94 (103,317) 25.43±3.93 (133,442) 25.40±3.96 (135,223) 25.48±3.96 (128,827) < 0.001*
HbA1c, % 7.25±1.28 (122,238) 7.09±1.16 (143,885) 7.11±1.11 (156,043) 6.99±1.02 (157,216) 6.97±1.05 (156,441) < 0.001*
Systolic blood pressure, mmHg 137.21±17.24 (165,921) 135.37±16.54 (174,233) 134.34±16.31 (181,851) 132.47±15.59 (178,029) 131.12±14.94 (170,211) < 0.001*
Diastolic blood pressure, mmHg 75.33±10.46 (165,921) 74.67±10.18 (174,233) 74.18±10.16 (181,851) 73.56±10.17 (178,029) 72.76±10.02 (170,211) < 0.001*
Triglyceride, mmol/L 1.71±1.10 (78,573) 1.56±1.02 (119,250) 1.52±0.97 (151,917) 1.44±0.90 (152,946) 1.42±0.87 (152,612) < 0.001*
TC/HDL-C ratio 4.45±1.31 (78,143) 4.20±1.24 (119,660) 3.87±1.15 (151,660) 3.64±1.09 (152,864) 3.52±1.03 (152,547) < 0.001*
LDL-C, mmol/L 3.12±0.85 (76,754) 3.00±0.82 (118,398) 2.74±0.78 (150,318) 2.55±0.73 (151,924) 2.44±0.70 (151,682) < 0.001*
eGFR, ml/min/1.73m2 80.21±56.56 (97,600) 81.88±32.83 (132,561) 83.14±30.57 (159,879) 82.12±29.66 (159,274) 81.49±25.10 (158,210) < 0.001*
Clinical Characteristics
Duration of diabetes, year (mean±SD, n) 6.90±6.33 (130,949) 7.13±6.42 (146,588) 7.39±6.53 (160,968) 8.15±6.54 (161,496) 9.07±6.50 (156,112) < 0.001*
Duration of diabetes, year (%, n) < 0.001*
≤ 5 years 51.52 % (67,465) 49.55 % (72,628) 47.84 % (77,003) 42.82 % (69,148) 36.09 % (56,340)
5-10 years 25.87 % (33,871) 26.93 % (39,479) 25.75 % (41,450) 28.08 % (45,344) 30.63 % (47,811)
> 10 years 22.61 % (29,613) 23.52 % (34,481) 26.41 % (42,515) 29.11 % (47,004) 33.28 % (51,961)
History of hypertension (%, n) 71.52 % (123,405) 73.15 % (130,927) 74.36 % (137,344) 76.66 % (138,062) 78.51 % (135,470) < 0.001*
Family history of diabetes mellitus (%, n) 13.26 % (22,875) 19.82 % (35,468) 21.85 % (40,359) 24.34 % (43,840) 21.89 % (37,762) < 0.001*
Insulin used (%, n) 1.62 % (2,800) 1.95 % (3,498) 2.55 % (4,715) 3.63 % (6,532) 4.24 % (7,313) < 0.001*
BMI = Body Mass Index; HbA1c = Haemoglobin A1c; TC = Total Cholesterol; HDL-C = High-Density Lipoprotein-Cholesterol ; LDL-C = Low-Density Lipoprotein-Cholesterol; 
eGFR = Estimated Glomerular Filtration Rate
Notes:
* Significant differences (P < 0.05) by Cochran-Armitage test
Year
Table 2. Temporal Trends in Quality of Diabetes Care of Primary Care Outpatient Clinics
Quality of care measure 2009 2010 2011 2012 2013 P-value for trend
Process of Care Criteria (%, n)
HbA1c test 70.84 % (122,238) 80.39 % (143,885) 84.49 % (156,043) 87.29 % (157,216) 90.67 % (156,441) <0.001*
Renal function test 56.59 % (97,638) 74.06 % (132,563) 86.57 % (159,880) 88.43 % (159,274) 91.69 % (158,210) <0.001*
Test for full lipid profile 44.86 % (77,408) 66.34 % (118,738) 82.10 % (151,622) 84.87 % (152,854) 88.41 % (152,539) <0.001*
Urine protein analysis 33.65 % (58,061) 51.73 % (92,600) 67.08 % (123,882) 71.65 % (129,055) 71.58 % (123,513) <0.001*
Prescription of lipid-lowering agent for 
patients with hypercholesterolaemia 23.02 % (14,754) 39.77 % (39,667) 54.37 % (64,749) 68.99 % (84,751) 77.05 % (96,027) <0.001*
Prescription of ACEI/ARB for patients with 
microalbuminuria 67.56 % (4,776) 71.38 % (11,374) 75.25 % (21,732) 78.70 % (24,246) 80.42 % (24,873) <0.001*
DMR screening NA 2.32 % (4,146) 34.37 % (63,483) 48.17 % (86,755) 40.63 % (70,107) <0.001*
Outcome of Care Criteria (%, n)
HbA1c ≤ 7% 52.13 % (63,728) 58.37 % (83,986) 57.40 % (89,565) 62.61 % (98,433) 64.06 % (100,220) <0.001*
BP ≤ 130/80 mmHg 31.51 % (52,280) 35.56 % (61,958) 37.69 % (68,544) 43.02 % (76,584) 48.21 % (82,061) <0.001*
LDL-C ≤ 2.6 mmol/L 28.29 % (21,711) 33.46 % (39,617) 46.97 % (70,605) 58.25 % (88,491) 65.44 % (99,256) <0.001*
HbA1c = Haemoglobin A1c; BP = Blood Pressure; LDL-C = Low-Density Lipoprotein-Cholesterol; ACEI = Angiotensin-Converting-Enzyme Inhibitor; 
ARB = Angiotensin Receptor Blocker; DMR = Diabetes Mellitus Retinopathy; NA = Not Applicable
Notes:
* Significant differences (P < 0.05) by Cochran-Armitage test
Year
Table 3. Unadjusted multi-level mixed effects logistic regressions
Quality of care measure OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Process of Care Criteria
HbA1c test (n = 888,885) 1.691 (1.665,1.718) <0.001* 2.253 (2.216,2.291) <0.001* 2.839 (2.790,2.889) <0.001* 4.033 (3.956,4.112) <0.001*
Renal function test (n = 888,885) 2.258 (2.225,2.291) <0.001* 5.254 (5.166,5.344) <0.001* 6.229 (6.120,6.341) <0.001* 9.115 (8.935,9.299) <0.001*
Test for full lipid profile (n = 888,885) 2.536 (2.500,2.572) <0.001* 6.147 (6.051,6.244) <0.001* 7.520 (7.397,7.645) <0.001* 10.388 (10.202,10.577) <0.001*
Urine protein analysis (n = 888,885) 2.158 (2.129,2.189) <0.001* 4.197 (4.138,4.257) <0.001* 5.210 (5.135,5.287) <0.001* 5.203 (5.126,5.280) <0.001*
Prescription of lipid-lowering agent for 
patients with hypercholesterolaemia (n = 
530,384)
2.240 (2.189,2.292) <0.001* 4.107 (4.016,4.199) <0.001* 7.960 (7.782,8.143) <0.001* 12.205 (11.923,12.493) <0.001*
Prescription of ACEI/ARB for patients with 
microalbuminuria (n = 113,618) 1.320 (1.241,1.404) <0.001* 1.615 (1.524,1.712) <0.001* 1.988 (1.875,2.109) <0.001* 2.209 (2.082,2.344) <0.001*
DMR screening (n = 716,334) 23.626 (22.871,24.405) <0.001* 43.145 (41.769,44.566) <0.001* 31.300 (30.299,32.334) <0.001*
Outcome of Care Criteria
HbA1c ≤ 7% (n = 735,823) 1.298 (1.278,1.318) <0.001* 1.246 (1.227,1.265) <0.001* 1.552 (1.529,1.576) <0.001* 1.655 (1.630,1.681) <0.001*
BP ≤ 130/80 mmHg (n = 870,245) 1.204 (1.187,1.222) <0.001* 1.321 (1.303,1.340) <0.001* 1.652 (1.629,1.675) <0.001* 2.042 (2.013,2.071) <0.001*
LDL-C ≤ 2.6 mmol/L (n = 649,076) 1.284 (1.259,1.310) <0.001* 2.251 (2.208,2.294) <0.001* 3.582 (3.515,3.651) <0.001* 4.904 (4.811,5.000) <0.001*
ACEI = Angiotensin-Converting-Enzyme Inhibitor; ARB = Angiotensin Receptor Blocker; DMR = Diabetes Mellitus Retinopathy; HbA1c = Haemoglobin A1c; BP = Blood Pressure;
LDL-C = Low-Density Lipoprotein-Cholesterol; OR = Odds Ratio; CI = Confidence Interval
Note:
* Significant with p-value < 0.05
† Reference category was year 2010 for DMR screening, and year 2009 for other process and outcome of care criteria
2012 vs 2009† 2013 vs 2009†
Reference due to no data in 2009
2010 vs 2009 2011 vs 2009†
Table 4. Adjusted multi-level mixed effects logistic regressions
Quality of care measure OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Process of Care Criteria
HbA1c test (n = 394,740) 1.308 (1.163,1.471) <0.001* 1.423 (1.261,1.606) <0.001* 2.956 (2.535,3.447) <0.001* 3.949 (3.286,4.745) <0.001*
Renal function test (n = 394,895) 1.439 (1.291,1.605) <0.001* 2.555 (2.257,2.893) <0.001* 2.963 (2.582,3.399) <0.001* 5.774 (4.814,6.925) <0.001*
Test for full lipid profile (n = 403,146) 2.702 (2.543,2.870) <0.001* 7.782 (7.199,8.412) <0.001* 16.553 (14.912,18.375) <0.001* 24.082 (21.108,27.476) <0.001*
Urine protein analysis (n = 392,483) 1.644 (1.579,1.712) <0.001* 3.053 (2.916,3.197) <0.001* 5.200 (4.931,5.483) <0.001* 2.645 (2.522,2.773) <0.001*
Prescription of lipid-lowering agent for 
patients with hypercholesterolaemia (n = 
296,475)
3.413 (3.286,3.545) <0.001* 5.498 (5.290,5.714) <0.001* 8.862 (8.526,9.212) <0.001* 11.892 (11.430,12.373) <0.001*
Prescription of ACEI/ARB for patients with 
microalbuminuria (n = 71,854) 1.421 (1.313,1.538) <0.001* 1.646 (1.526,1.776) <0.001* 1.953 (1.809,2.110) <0.001* 2.050 (1.894,2.220) <0.001*
DMR screening (n = 341,850) 59.861 (57.421,62.404) <0.001* 222.189 (212.781,232.012) <0.001* 137.369 (131.630,143.358) <0.001*
Outcome of Care Criteria
HbA1c ≤ 7% (n = 392,773) 1.281 (1.251,1.312) <0.001* 1.165 (1.138,1.194) <0.001* 1.448 (1.413,1.484) <0.001* 1.584 (1.544,1.624) <0.001*
BP ≤ 130/80 mmHg (n = 392,483) 1.242 (1.212,1.273) <0.001* 1.307 (1.275,1.340) <0.001* 1.609 (1.569,1.649) <0.001* 1.883 (1.836,1.931) <0.001*
LDL-C ≤ 2.6 mmol/L (n = 392,863) 1.269 (1.238,1.302) <0.001* 2.259 (2.203,2.316) <0.001* 3.488 (3.401,3.576) <0.001* 4.564 (4.449,4.682) <0.001*
ACEI = Angiotensin-Converting-Enzyme Inhibitor; ARB = Angiotensin Receptor Blocker; DMR = Diabetes Mellitus Retinopathy; HbA1c = Haemoglobin A1c; BP = Blood Pressure;
LDL-C = Low-Density Lipoprotein-Cholesterol; OR = Odds Ratio; CI = Confidence Interval
Note:
* Significant with p-value < 0.05
† Reference category was year 2010 for DMR screening, and year 2009 for other process and outcome of care criteria
All models are adjusted by baseline characteristics
2013 vs 2009†
Reference due to no data in 2009
2010 vs 2009 2011 vs 2009† 2012 vs 2009†
